Poging GOUD - Vrij
Israel-Iran conflict spurs China to reconsider Russian gas pipeline
Mint Kolkata
|June 26, 2025
The war between Israel and Iran has revived Chinese leaders' interest in a pipeline that would carry Russian natural gas to China, according to people close to Beijing's decision-making, potentially jump-starting a project that has been stalled for years.
The Power of Siberia 2 pipeline project has been mired in disagreements over pricing and ownership terms, as well as Chinese concerns about relying too heavily on Russia for its energy supplies. But the recent war in the Middle East has given Beijing reason to reconsider the reliability of the oil and natural gas it gets from the region, the people said, even as a fragile cease-fire between Israel and Iran takes hold.
China imports around 30% of its gas in the form of liquefied natural gas from Qatar and the United Arab Emirates via the Strait of Hormuz, a maritime chokepoint that Iran threatened to close, according to consulting firm Rystad Energy. Meanwhile, China's independent refineries, known as teapots, have in recent years become hooked on cheap Iranian crude.
More than 90% of Iran's oil exports now go to China, analysts say, even though the U.S. has sanctions designed to prevent Iran from selling its oil abroad. Trump made an unusual acknowledgment of China's Iranian oil imports Tuesday after announcing a cease-fire in the Israel-Iran conflict. "China can now continue to purchase oil from Iran. Hopefully, they will be purchasing plenty from the U.S., also," he said in a post on social media.
A White House official later said Trump was simply calling attention to the fact that the cease-fire prevented disruption to oil flows through the Strait of Hormuz. He continues to call on China to import U.S. oil rather than Iranian oil in violation of U.S. sanctions, the official said.
But, even with a cease-fire in place, the recent conflict has spurred Beijing to cast about for alternatives, the people and analysts say.
Dit verhaal komt uit de June 26, 2025-editie van Mint Kolkata.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint Kolkata
Mint Kolkata
Images of a city in perpetual motion
An ongoing exhibition of Raghubir Singh's photographs from the 1970s-90s captures the changing nature of life in Mumbai
4 mins
April 30, 2026
Mint Kolkata
The UAE’s departure from OPEC may not break the cartel
WHEN THE Organisation of the Petroleum Exporting Countries (OPEC) meets on April 29th, the club will be contemplating the departure of one of its longest-standing members.
3 mins
April 30, 2026
Mint Kolkata
MUFG to start India realty lending
Mitsubishi UFJ Financial Group Inc. (MUFG) will start lending to real estate firms in India and expand its foreign exchange derivatives business in the country’s low-tax hub, as it seeks to deepen its presence in the world’s fastest-growing major economy.
1 min
April 30, 2026
Mint Kolkata
Gautam Anand to head HSBC unit
HSBC on Wednesday named Gautam Anand to head its global India private banking division as the lender looks to strengthen cross-border services for wealthy clients with links to India.
1 min
April 30, 2026
Mint Kolkata
MakeMyTrip hiring banks for India IPO
MakeMyTrip Ltd, an online travel platform listed on the Nasdaq, is considering a listing in Mumbai, people familiar with the matter said.
1 min
April 30, 2026
Mint Kolkata
Canada nod for DRL's GLP-1 shot
Dr Reddy's Laboratories (DRL) on Wednesday said it has received a notice of compliance (NoC) from Health Canada for its generic semaglutide injection indicated for the management of type-2 diabetes.
1 min
April 30, 2026
Mint Kolkata
Will Opec crack up with the UAE's exit? Unlikely
With Gulf rifts widened by war, the UAE's plan to quit Opec is a blow for this powerful oil cartel. It ll have major consequences, but convergent economic interests could keep it going
2 mins
April 30, 2026
Mint Kolkata
Piramal Pharma bets big on complex therapies
India’s Piramal Pharma hopes to accelerate earnings growth over the next two to three years, led by rising demand for complex drugs, including targeted cancer therapies, a top executive said on Wednesday.
1 min
April 30, 2026
Mint Kolkata
Irdai to tweak rules to curb insurance mis-selling
India's insurance regulator is planning a sweeping overhaul of how policies are sold, including tighter scrutiny of banks and a discussion paper on distribution reforms, as it looks to curb mis-selling and high costs in the sector.
1 min
April 30, 2026
Mint Kolkata
Why rate cuts don't benefit every home loan borrower
Many lenders adjust loan tenure instead of EMIs, quietly increasing the total interest paid
4 mins
April 30, 2026
Listen
Translate
Change font size

